免疫チェックポイント阻害剤で治療された患者の高いトロポニンレベルの実際の管理
Lior Zornitzki1,2, Dana Viskin1,2, Ophir Freund2,3
1Division of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
CJC open
|September 2, 2025
まとめ
免疫チェックポイント阻害剤 (ICI) 療法は,高感度トロポニンI (hs- TnI) によって検出される心筋損傷を引き起こす可能性があります. 現実の世界での管理は様々なアプローチと心臓病の介入が少ないことが示され,ICIに関連する心臓病の管理のための標準化されたプロトコルの必要性を強調しています.
科学分野:
- 心臓腫瘍学
- 免疫療法
- 心臓バイオマーカー
背景:
- 免疫チェックポイント阻害剤 (ICI) はがん治療に変化をもたらしましたが,心筋損傷を引き起こす可能性があります.
- 現在のガイドラインには,ICI治療中のトロポニン濃度の上昇管理のための具体的なプロトコルがない.
- トロポニンの定期的なモニタリングは推奨されますが,臨床評価と管理戦略は異なります.
研究 の 目的:
- 高感度トロポニンI (hs- TnI) レベルが上昇したICIで治療された患者の実際の評価と管理を記述する.
- ICIに関連した心筋損傷の患者の臨床結果と介入の評価.
主な方法:
- テルアビブ・ソーラスキー医療センターでのICI治療中にhs- TnIの定期的なモニタリングを受けている患者の遡及的分析.
- hs-TnI > 50 ng/ Lの患者に対する心電図,心声検査,心臓科の診察,治療決定を含む臨床データの評価
主要な成果:
- 患者の11% (50/455) がICI治療後のhs- TnI値上昇を示した (中位は159ng/ L).
- 10%は心電図の変化,8%は心音の異常を示した.
- 26% の患者には,可能性のある心筋炎が診断され,コルチコステロイド治療 (84%) とICI治療の中止 (92%) が求められました.
結論:
- この研究では,日常的なICI監視の際の上昇したhs-TnIの管理について説明しています.
- 治療方法の有意な多様性,心臓病の診察の制限,および治療中断の高い割合が観察されました.
- ICI治療を受けている患者におけるhs- TnI濃度の上昇については,標準化された管理ガイドラインが必要である.
さらに関連する動画
関連する概念動画
Myocarditis III: Medical Management
15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Myocarditis IV: Nursing Management
26
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
26
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
Pericarditis III: Medical Management
26
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26
Pericarditis IV: Nursing Management
50
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
50
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
